ロード中...
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Emerging coronaviruses (CoVs) cause severe disease in humans, but no approved therapeutics are available. The CoV nsp14 exoribonuclease (ExoN) has complicated development of antiviral nucleosides due to its proofreading activity. We recently reported that the nucleoside analogue GS-5734 (remdesivir)...
保存先:
| 出版年: | mBio |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844999/ https://ncbi.nlm.nih.gov/pubmed/29511076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mBio.00221-18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|